Please login to the form below
Jinarc backed for European approval in rare kidney disease
Positive opinion for Otsuka comes just before rare disease awareness day
UCB boosted by core medicines growth
Firm’s new chief executive 'excited' by his company’s next batch of medicines
Sovaldi-Daklinza combo cures hep C in co-infected HIV patients
Phase III trial of BMS and Gilead antivirals cured 97% of patients
Bayer's Eylea cleared for wider use in Europe
Macular oedema treatment reached €759m in sales last year
Gilead's Sovaldi wins NICE approval but faces access delay
The Institute also recommends Janssen's hepatitis C drug Olysio
Sanofi gets green light for Lantus follow-up Toujeo
Once-daily basal insulin gains FDA approval for diabetes
Actavis gets FDA nod for new antibiotic
Avycaz is the fifth antibiotic to gain US approval in recent months
BMS buys immunotherapy specialist Flexus in $1.2bn deal
And signs new cancer research partnership with Rigel
Shire boosts orphan drug pipeline with Meritage Pharma deal
Firm will also acquire global rights to Meritage’s phase III OBS compound
2015: A year of promise and connectivity
How could technology impact healthcare in this year and what will be the key trends to follow?
-
Future gazing: What does 2015 hold for NICE?Undermined by the CDF, the Institute is set to face a number of challenges this year
-
England's Cancer Drugs Fund: Fixing a broken systemFollowing the culling of 16 medicines from the Fund PME looks at how to improve market access for new oncology products
-
Remicade biosimilars hit European marketHospira and Mundipharma begin marketing their version of the blockbuster drug
-
Takeda grows in Turkey with Neutec subsidiary acquisitionWill acquire Toplam Kalite for up to 300m Turkish lira
-
US lawmaker pushes for drug price transparency If passed a new Bill would demand pharma show how product price tags are worked out
-
Merck rode out rival to sign $450m deal with NGMPart of a five-year alliance on metabolic disorders and cancer
-
Good NICE news for Pfizer, but Dendreon drug rejected Kidney cancer drug Inlyta backed but prostate cancer treatment Provenge is not
-
Rosetta merges with Razorfish Healthware to launch new agencyMerger will create Razorfish Health
-
UK doctors call on NHS to use Avastin for wet AMDControversial practice of using the drug off-label could save the health service £102m
Latest appointments
-
UCB CEO elected to the Ministerial Industry Strategy GroupJean-Christophe Tellier assumed the role of CEO on January 1
-
Werner Baumann to replace Brandicourt at BayerWill assume the role of chairman after the former boss jumped ship to Sanofi
-
Kymab names Anne Hyland as chief financial officerHyland joins from BBI Diagnostics
-
Everyday Health appoints PHCG presidentMichael du Toit to take up same position
-
W Communications strengthens management teamSunil Ramkali and Elisabet Ek join as partners
Featured jobs
- FREELANCE!! Account Manager / Senior Account Manager – TOP 5 Hea...
-
VERY COMPETITIVE DAY RATE
- Associate Project Director – Meetings Management - Reading, Berk...
-
Competitive + excellent benefits
- Experienced Medical Writer MILAN – ITALY – Medical Education – R...
-
Excellent Remuneration & Relocation Assistance
- Account Executive and Senior Account Executive NEEDED for FUN &...
-
Bonus + Benefits
- Business Unit Director – Consumer Healthcare Advertising – South...
-
Very lucrative remuneration on offer
- Director – Client Engagement – Brand Team - Reading, Berkshire...
-
Senior level salary + comprehensive benefits
- Senior Medical Writer
-
Competitive Salary Offered
DGH Recruitment
- Assistant Editor – Clinical Pharmacy: The Pharmaceutical Journal...
-
Competitive Salary Offered
- AM or Senior Account Manager – Digital – Healthcare Advertising ...
-
EXTENSIVE PACKAGE AVAILABLE
- Healthcare PR Account Manager, Internal Communications
-
c£30-35,000 according to skills and experience
- Account Manager & Senior Account Manager – Medical Communica...
-
£33000 - £48000 + BONUS + BENEFITS
Subscribe to our email news alerts
- Early win for Pfizer as Remicade biosimilar launches in West Europe
- England's Cancer Drugs Fund: Fixing a broken system
- Boehringer in breach over beer drinking, lederhosen presentation
- Pharma firms violate marketing regulations every week, claims study
- Advagraf shows survival increase for liver transplant patients
- Novartis' heart failure drug could get FDA nod in summer
PMHub
Swordfish Advertising
At Swordfish Advertising, we believe building an effective brand shouldn't be stressful. Don't get us wrong; it takes blood, sweat...
Latest intelligence
- Russian innovation at the crossroads
- Despite improvements, investors face rising risks...
- E-detailing content wow factor in 2015
- Many companies are reporting that the iPad novelty has worn off and healthcare professionals are demanding more than just another animation presented on a mobile device. So what exactly are...
- Free White Paper: Multichannel Marketing for Pharma
- Transitioning successfully to multichannel marketing takes careful planning. When done right, pharma can deliver a personalised experience for each customer. Download our white paper to learn how...
Quick links
